CompanyTELONasdaqMiami, FL

Telomir Pharmaceuticals, Inc.

Telomir Pharmaceuticals develops small-molecule therapeutics targeting epigenetic and metabolic pathways in cancer.

SEC EDGAR ClinicalTrials.gov telomirpharma.com

10-QNov 6Latest SEC filing

Oct 6Latest story

October 2026

Telomir Pharmaceuticals closes $5.6 million PIPE as DeJoria adds to stake

Oct 6FinancingTelomir Pharmaceuticals, Inc.